1001 lights: luciferins, luciferases, their mechanisms of action and applications in chemical analysis, biology and medicine

ZM Kaskova, AS Tsarkova, IV Yampolsky - Chemical Society Reviews, 2016 - pubs.rsc.org
Bioluminescence (BL) is a spectacular phenomenon involving light emission by live
organisms. It is caused by the oxidation of a small organic molecule, luciferin, with molecular …

Recent advances in the mechanisms of lung alveolarization and the pathogenesis of bronchopulmonary dysplasia

DMG Silva, C Nardiello, A Pozarska… - American Journal of …, 2015 - journals.physiology.org
Alveolarization is the process by which the alveoli, the principal gas exchange units of the
lung, are formed. Along with the maturation of the pulmonary vasculature, alveolarization is …

An official American Thoracic Society workshop report: use of animal models for the preclinical assessment of potential therapies for pulmonary fibrosis

RG Jenkins, BB Moore, RC Chambers… - American journal of …, 2017 - atsjournals.org
Numerous compounds have shown efficacy in limiting development of pulmonary fibrosis
using animal models, yet few of these compounds have replicated these beneficial effects in …

Role of epithelial sodium channels in the regulation of lung fluid homeostasis

S Matalon, R Bartoszewski… - American Journal of …, 2015 - journals.physiology.org
In utero, fetal lung epithelial cells actively secrete Cl− ions into the lung air spaces while Na+
ions follow passively to maintain electroneutrality. This process, driven by an …

[HTML][HTML] In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach

L Mecozzi, M Mambrini, F Ruscitti, E Ferrini… - Scientific reports, 2020 - nature.com
Although increasing used in the preclinical testing of new anti-fibrotic drugs, a thorough
validation of micro-computed tomography (CT) in pulmonary fibrosis models has not been …

Optimising experimental research in respiratory diseases: an ERS statement

P Bonniaud, A Fabre, N Frossard… - European …, 2018 - Eur Respiratory Soc
Experimental models are critical for the understanding of lung health and disease and are
indispensable for drug development. However, the pathogenetic and clinical relevance of …

Longitudinal micro-CT provides biomarkers of lung disease that can be used to assess the effect of therapy in preclinical mouse models, and reveal compensatory …

G Vande Velde, J Poelmans… - Disease models & …, 2016 - journals.biologists.com
In vivo lung micro-computed tomography (micro-CT) is being increasingly embraced in
pulmonary research because it provides longitudinal information on dynamic disease …

[HTML][HTML] In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery

A Woods, A Patel, D Spina, Y Riffo-Vasquez… - Journal of Controlled …, 2015 - Elsevier
The development of clinically acceptable albumin-based nanoparticle formulations for use in
pulmonary drug delivery has been hindered by concerns about the toxicity of nanomaterials …

[HTML][HTML] Quantification of pulmonary fibrosis in a bleomycin mouse model using automated histological image analysis

JC Gilhodes, Y Julé, S Kreuz, B Stierstorfer, D Stiller… - PloS one, 2017 - journals.plos.org
Current literature on pulmonary fibrosis induced in animal models highlights the need of an
accurate, reliable and reproducible histological quantitative analysis. One of the major limits …

Quantitative comparison of three widely-used pulmonary administration methods in vivo with radiolabeled inhalable nanoparticles

L Wu, C Rodríguez-Rodríguez, D Cun, M Yang… - European Journal of …, 2020 - Elsevier
Pulmonary formulations have been attracting much attention because of their direct effects
on respiratory diseases, but also their non-invasive administration for the treatment of …